Patent 10195202 was granted and assigned to Ptc Therapeutics, Inc. on February, 2019 by the United States Patent and Trademark Office.
Described herein are methods for modulating the amount of a gene product and compounds for use in such methods. More particularly, described herein are methods for modulating the amount of an RNA transcript or protein product as the result of gene expression and compounds for use in such methods.